SEC Comment Letter for NYMOX PHARMACEUTICAL CORP (NYMXF) (CIK 0001018735) (NYMXF) — Oct 27, 2005

NYMOX PHARMACEUTICAL CORP (NYMXF) (CIK 0001018735)
Date: Oct. 27, 2005 · CIK: 0001018735 · Accession: 0000000000-05-054658

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-12033

Date

October 27, 2005

Author

Jim Atkinson

Form

UPLOAD

Company

NYMOX PHARMACEUTICAL CORP (NYMXF) (CIK 0001018735)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 October 27, 2005 Mr. Roy Wolvin Chief Financial Officer Nymox Pharmaceutical Corporation 9900 Cavendish Blvd., Suite 306 St. Laurent, Quebec H4M 2V2 CANADA

Re: Nymox Pharmaceutical Corporation Form 20-F for the Fiscal Year Ended December 31, 2004 Filed June 30, 2005 File No. 001-12033

Dear Mr. Wolvin:

We have completed our review of your Form 20-F and have no further comments at this time.

Sincerely,
Jim Atkinson
Accounting Branch Chief

Show Raw Text

<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

Via Facsimile and U.S. Mail
Mail Stop 6010

October 27, 2005

Mr. Roy Wolvin
Chief Financial Officer
Nymox Pharmaceutical Corporation
9900 Cavendish Blvd., Suite 306
St. Laurent, Quebec  H4M 2V2
CANADA

Re:	Nymox Pharmaceutical Corporation
	Form 20-F for the Fiscal Year Ended December 31, 2004
	Filed June 30, 2005
	File No. 001-12033

Dear Mr. Wolvin:

      We have completed our review of your Form 20-F and have no
further comments at this time.

Sincerely,

      Jim Atkinson
								Accounting Branch Chief

??

??

??

??

</TEXT>
</DOCUMENT>

SecProbe.io